We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$33.8B
AUM Growth
+$2.87B
Cap. Flow
+$1.54B
Cap. Flow %
4.54%
Top 10 Hldgs %
16.03%
Holding
1,494
New
35
Increased
872
Reduced
242
Closed
39

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$273M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$151M
3
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$131M
4
DD icon
DuPont de Nemours
DD
+$103M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$59.3M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$254M
2
DD
Du Pont De Nemours E I
DD
+$89.3M
3
RAI
Reynolds American Inc
RAI
+$76.3M
4
MRK icon
Merck
MRK
+$41.1M
5
CHTR icon
Charter Communications
CHTR
+$34.1M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 16.04%
3 Healthcare 13.34%
4 Industrials 10.24%
5 Communication Services 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLSD
1426
DELISTED
Clearside Biomedical
CLSD
$131K ﹤0.01%
1,000
– –
ADXS
1427
DELISTED
Advaxis Inc
ADXS
$130K ﹤0.01%
2,067
– –
CRIS icon
1428
Curis
CRIS
$3.49M
$128K ﹤0.01%
43
– –
NEOS
1429
DELISTED
Neos Therapeutics, Inc
NEOS
$128K ﹤0.01%
14,000
– –
IMDZ
1430
DELISTED
Immune Design Corp.
IMDZ
$124K ﹤0.01%
12,000
– –
FATE icon
1431
Fate Therapeutics
FATE
$317M
$119K ﹤0.01%
30,000
– –
AVXL icon
1432
Anavex Life Sciences
AVXL
$316M
$118K ﹤0.01%
29,000
– –
KIN
1433
DELISTED
Kindred Biosciences, Inc.
KIN
$118K ﹤0.01%
15,000
– –
CEMP
1434
DELISTED
Cempra, Inc.
CEMP
$117K ﹤0.01%
36,000
– –
CASC
1435
DELISTED
Cascadian Therapeutics, Inc.
CASC
$115K ﹤0.01%
28,000
– –
OCUL icon
1436
Ocular Therapeutix
OCUL
$2.25B
$111K ﹤0.01%
18,000
– –
FBIO icon
1437
Fortress Biotech
FBIO
$91.4M
$110K ﹤0.01%
1,667
– –
HSTO
1438
DELISTED
Histogen Inc. Common Stock
HSTO
$110K ﹤0.01%
100
– –
SBBP
1439
DELISTED
Strongbridge Biopharma plc.
SBBP
$110K ﹤0.01%
16,000
– –
TRVN
1440
DELISTED
Trevena, Inc.
TRVN
$102K ﹤0.01%
64
– –
SCTL
1441
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$99K ﹤0.01%
12,265
– –
IBRX icon
1442
ImmunityBio
IBRX
$8.2B
$93K ﹤0.01%
17,000
– –
VRDN icon
1443
Viridian Therapeutics
VRDN
$2.59B
$91K ﹤0.01%
667
– –
NYMX
1444
DELISTED
Nymox Pharmaceutical Corp
NYMX
$84K ﹤0.01%
22,000
– –
NVLN
1445
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$77K ﹤0.01%
11,000
– –
VBIV
1446
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$65K ﹤0.01%
567
– –
AST
1447
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$65K ﹤0.01%
19,000
– –
OTIC
1448
DELISTED
Otonomy, Inc.
OTIC
$62K ﹤0.01%
19,000
– –
ARAV
1449
DELISTED
Aravive, Inc. Common Stock
ARAV
$59K ﹤0.01%
4,000
– –
GIGM icon
1450
GigaMedia
GIGM
$16.5M
$51K ﹤0.01%
15,747
– –
56 57
58
59 60

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q3 2017 Portfolio in Review

As of Q3 2017, State of Wisconsin Investment Board held 1,494 positions worth $33.8B, up 9.2% from $31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board deployed $1.54B of net new capital in Q3 2017, opening 35 new positions and adding to 872 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 6,728,154 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $254M trimmed.

  • State of Wisconsin Investment Board's largest Q3 2017 buy was Discovery, Inc. Series C Common Stock: 6,728,154 shares worth $136M.
  • State of Wisconsin Investment Board added most to Alphabet (Google) Class A in Q3 2017, an estimated $273M increase.
  • State of Wisconsin Investment Board's biggest Q3 2017 reduction was Alphabet (Google) Class C, cutting an estimated $254M.
  • State of Wisconsin Investment Board fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $89.3M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $33.8B portfolio in Q3 2017.
  • State of Wisconsin Investment Board opened 35 new positions and closed 39 in Q3 2017.
  • State of Wisconsin Investment Board's portfolio value rose 9.2% quarter-over-quarter to $33.8B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2017, filed 1 Nov 2017.